Table 2.
Pharmacokinetic parameters of two consecutive injections of rhIL-2 at 10×106 IU m−2 s.c. every 12 h in patients with metastatic renal cell cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.